Overview

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.
Phase:
Phase 4
Details
Lead Sponsor:
Nebraska Methodist Health System
Treatments:
Labetalol
Nifedipine